ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2020
[Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients].
Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19.Respiration; international review of thoracic diseases · 2020Guideline
- Nursing Interventions Related to the Need for Oxygenation in Severe COVID-19 Disease in Hospitalized Adults: A Retrospective Study.Nursing reports (Pavia, Italy) · 2024Article
- High flow nasal oxygen (HFNO) in the treatment of COVID-19 infection of adult patients from - An emergency perspective: A systematic review and meta-analysis.Trends in anaesthesia & critical care · 2023Review
- Development and evaluation of an e-learning course in oxygen therapy.BMC medical education · 2022Article
- Design and engineering application of medical oxygen supply system in novel coronavirus pneumonia treatment hospital.Journal of building engineering · 2021Article
- Use of high-flow nasal cannula in COVID-19 has improved effectiveness, safety and tolerability when applied in lateral position compared with prone positioning.Intensive & critical care nursing · 2021Article
- High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure.BMJ open respiratory research · 2021Article
- The COVID-19 pandemic: the effect on airway Management in non-COVID emergency patients.BMC emergency medicine · 2021Article
- Exhalation Spreading During Nasal High-Flow Therapy at Different Flow Rates.Critical care medicine · 2021Article
- Review of registered clinical trials for the treatment of COVID-19.Drug development research · 2021Review
- Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units (WARd-COVID).Annals of the American Thoracic Society · 2021Observational
- High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study.Annals of intensive care · 2021Article
- The Considerations and Controversies in Using High-Flow Nasal Oxygen with Self-Prone Positioning in SARS-CoV-2 COVID-19 Disease.Case reports in critical care · 2021Article
- Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets.Acta pharmacologica Sinica · 2020Review
- Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients.European review for medical and pharmacological sciences · 2020Article
- Hypoxemia Index Associated with Prehospital Intubation in COVID-19 Patients.Journal of clinical medicine · 2020Article
- [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].Pneumologie (Stuttgart, Germany) · 2020Article
- The efficiency of high-flow nasal cannula for adult patients with coronavirus disease 19 in Jeddah, Saudi Arabia.Annals of thoracic medicineArticle
- Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.Therapeutic advances in respiratory diseaseObservational
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute respiratory failure due to acute hypoxemia is the major manifestation in severe coronavirus disease 2019 (COVID-19). Rational and effective respiratory support is crucial in the management of COVID-19 patients. High-flow nasal cannula (HFNC) has been utilized widely due to its superiority over other non-invasive respiratory support techniques. To avoid HFNC failure and intubation delay, the key issues are proper patients, timely application and improving compliance. It should be noted that elder patients are vulnerable for failed HFNC. We applied HFNC for oxygen therapy in severe and critical ill COVID-19 patients and summarized the following experiences. Firstly, to select the proper size of nasal catheter, to locate it at suitable place, and to confirm the nose and the upper respiratory airway unobstructed. Secondly, an initial ow of 60 L/min and 37℃ should be given immediately for patients with obvious respiratory distress or weak cough ability; otherwise, low-level support should be given first and the level gradually increased. Thirdly, to avoid hypoxia or hypoxemia, the treatment goal of HFNC should be maintained the oxygen saturation (SpO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.